Amneal Pharmaceuticals (AMRX) Accounts Payables (2017 - 2026)

Amneal Pharmaceuticals' Accounts Payables history runs 10 years deep, the most recent figure standing at $38000.0 for Q1 2026.

• In Q1 2026, Accounts Payables rose 1800.0% year-over-year to $38000.0; the TTM figure through Mar 2026 stood at $38000.0 (up 1800.0% YoY), while the FY2025 annual figure was $26000.0, down 56.67% from the prior year.
• Accounts Payables was $38000.0 for Q1 2026 at Amneal Pharmaceuticals, up from $26000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $671.1 million in Q3 2024 to a low of $2000.0 in Q1 2025.
• Historically, Accounts Payables has averaged $227.9 million across 5 years, with a median of $7.4 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables tumbled 99.9% in 2023, then soared 19073.86% in 2024.
• A 5-year view of Accounts Payables shows it stood at $538.2 million in 2022, then sank by 99.9% to $549000.0 in 2023, then sank by 89.07% to $60000.0 in 2024, then sank by 56.67% to $26000.0 in 2025, then surged by 46.15% to $38000.0 in 2026.
• The last three Accounts Payables figures came in at $38000.0 (Q1 2026), $26000.0 (Q4 2025), and $37.1 million (Q3 2025), per Business Quant data.